Pacific Biosciences of California, Inc. focuses on the development and commercialization of a transformative platform for single molecule, real-time detection of biological events. It plans to offer PacBio RS, an instrument that conducts, monitors, and analyzes single molecule biochemical sequencing reactions in real time by using its proprietary single molecule, real-time, or SMRT technology. The company's instrument would be used in DNA sequencing market. It intends to sell its product to genome centers, clinical institutions, government and academic institutions, genomics service providers, and agricultural companies. The company was formerly known as Nanofluidics, Inc. and changed its name to Pacific Biosciences of California, Inc. in 2005. Pacific Biosciences of California, Inc. was founded in 2000 and is headquartered in Menlo Park, California.